Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel)
Phase 4
- Conditions
- Acne Papulopustulosa
- Interventions
- Radiation: VIS and wIRADrug: Adapalen
- Registration Number
- NCT00237978
- Lead Sponsor
- Technische Universität Dresden
- Brief Summary
The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4
- At least 5 inflammatory and 5 non-inflammatory lesions in the face
- Age >= 14 years
Exclusion Criteria
- pregnant and nursing women
- Antiandrogen therapy
- therapy with antibiotics within the last 4 weeks
- therapy with retinoids within the last 6 months
- natural or artificial UV-therapy within the last 4 weeks
- severe acne papulopustulosa according to Burton Scale 5 or 6
- Severe systemic condition
- Secondary acne
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 VIS and wIRA VIS and wIRA 2 Adapalen VIS, wIRA and Adapalen 2 VIS and wIRA VIS, wIRA and Adapalen 3 Adapalen Adapalen
- Primary Outcome Measures
Name Time Method reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
🇩🇪Dresden, Sachsen, Germany